Ensign Group (NASDAQ:ENSG) is set to give its latest quarterly earnings report on Wednesday, 2026-02-04. Here's what investors need to know before the announcement.
Analysts estimate that Ensign Group will report an earnings per share (EPS) of $1.70.
Investors in Ensign Group are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
During the last quarter, the company reported an EPS beat by $0.10, leading to a 0.05% increase in the share price on the subsequent day.
Here's a look at Ensign Group's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 1.54 | 1.49 | 1.49 | 1.48 |
| EPS Actual | 1.64 | 1.59 | 1.52 | 1.49 |
| Price Change % | 0.00 | 9.00 | 1.00 | -9.00 |
Market Performance of Ensign Group's Stock
Shares of Ensign Group were trading at $172.56 as of February 02. Over the last 52-week period, shares are up 15.15%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Analyst Observations about Ensign Group
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Ensign Group.
Analysts have provided Ensign Group with 4 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $206.5, suggesting a potential 19.67% upside.
Comparing Ratings Among Industry Peers
The following analysis focuses on the analyst ratings and average 1-year price targets of Universal Health Services, PACS Group and Brookdale Senior Living, three prominent industry players, providing insights into their relative performance expectations and market positioning.
Analysis Summary for Peers
The peer analysis summary provides a snapshot of key metrics for Universal Health Services, PACS Group and Brookdale Senior Living, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.
Key Takeaway:
Ensign Group ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.
Get to Know Ensign Group Better
Understanding the Numbers: Ensign Group's Finances
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Ensign Group's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 19.84%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.47%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.05%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.65%, the company showcases effective utilization of assets.
Debt Management: Ensign Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.02.
To track all earnings releases for Ensign Group visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

